APP and Alzheimer disease: In a recent study, transgenic mice with familial Alzheimer’s disease (5×FAD mice) treated with AZ1 showed significant reductions in the amount of APP and amyloid plaques in the cerebral cortex, suggesting that AZ1 improved amyloid overload in an AD mouse model through pharmacological inhibition of USP25 [152].